http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2012120833-A

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2121-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P39-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7016
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-04
filingDate 2010-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2014-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2012120833-A
titleOfInvention COMPOSITIONS BASED ON HYPERSULPHATED DISACCHARIDES
abstract 1. A pharmaceutical composition comprising a compound of Formula I and pharmaceutically acceptable salts of R, R, R, R, R, and R are independently selected from the group consisting of H, SOH, or POH, provided that at least two of R-R are selected from SOH or RON, and delivery agent. 2. The composition according to claim 1, characterized in that at least three of R-R are selected from SOH or POH. 3. The composition according to claim 1, characterized in that at least four of the R-R are selected from SOH or RON. The composition according to claim 1, characterized in that at least five of R1-R6 are selected from SOH or POH. The composition according to claim 1, characterized in that R-R are selected from SOH or POH. 6. A pharmaceutical composition containing a compound of formula I and its pharmaceutically acceptable R, R, R, R and R and R independently are independently selected from H, SOH, or POH, and R3 is independently selected from SOH or POH, and a delivery agent. A pharmaceutical composition containing a compound of formula I and its pharmaceutically acceptable R, R, R, and R moieties are independently selected from H, SOH, or POH, and R and R are independently selected from SOH or POH, and a delivery agent selected from the group consisting of a pharmaceutically acceptable natural or synthetic polymer. 8. A pharmaceutical composition containing (i) a compound of formula I and its pharmaceutically acceptable solids where R, R, and R are independently selected from H, SOH, or POH, and R, R and R are independently selected from SOH or POH, and (ii) a delivery agent. A pharmaceutical composition comprising (i) a compound of formula II and pharmaceutically acceptable salts thereof, wherein R, R, P, R and R are independently selected from the group consisting of H, SOH or POH, and (ii) a delivery agent. A composition comprising a compound of formula I wherein R-R are pharmaceutically acceptable salts thereof and a delivery agent selected from a hydrophilic polymer. 11. The composition of claim 10, wherein
priorityDate 2009-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6581
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP49290
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCF6YEM5
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCG3WGK2
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID8288
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA0A4X2L956
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP11678
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280493
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419588377
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100331172
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID337514
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474364
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP80550
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID13861

Total number of triples: 53.